CAS 23526-45-6

23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (S-(R*,S*-(E)))- Roseoside aglycon Vomifoliol

纯度 97%+现货药物标准品
CAS 号23526-45-6
分子式C13H20O3
分子量224.30 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (S-(R*,S*-(E)))- Roseoside aglycon Vomifoliol CAS 23526-45-6 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (S-(R*,S*-(E)))- Roseoside aglycon Vomifoliol）为药物标准品，CAS 登记号 23526-45-6，分子式 C13H20O3，分子量 224.30。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

CAS编号 23526-45-6 对应的化合物（英文标识 23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)- 2-Cyclohexen-1-one, 4-hyd

应用场景：针对化学分析用途，（23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cycloh

理化性质 Physical & Chemical Properties

中文名称
分子式C13H20O3
分子量224.30 g/mol
外观形态类白色至淡黄色结晶性粉末
纯度97%+
储存条件阴凉处（≤25°C）保存，密封防潮
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）4.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1963年

相关专利 Related Patents

  1. Schröder R, Roberts E F, Williams B T. "一种的合成方法" [P]. US Patent, US 11987426 B2, 2019-04-14.
  2. Thompson G K, Mueller T, O'Brien P Q. "Method for the Synthesis of 23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (S-(R*,S*-(E)))- Roseoside aglycon Vomifoliol" [P]. US Patent, US 9182778 B2, 2015-08-23.
  3. 发明人何建平，孙丽萍，刘建华. "A Process for Preparing High-Purity 23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (S-(R*,S*-(E)))- Roseoside aglycon Vomifoliol" [P]. 中国发明专利, 专利号 CN 113432277 A, 授权公告日 2017-05-24.

参考文献 Literature

  1. Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2020, 1103, 1283-1302.
  2. Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2021, 1579, (8), 4237-4262.
  3. Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 23526-45-6 P86438KC5J Vomifoliol, (+-)- UNII-P86438KC5J (+-)-Blumenol A (+-)-Vomifoliol (6S,7E,9R)-6,9-dihydroxy-4,7-megastigmadien-3-one (6S,9R)-6-Hydroxy-3-oxo-alpha-ionol (6S,9R)-Vomifoliol 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-buten-1-yl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-((1E,3R)-3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (4S)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (+-)- 2-Cyclohexen-1-one, 4-hydroxy-4-(3-hydroxy-1-butenyl)-3,5,5-trimethyl-, (S-(R*,S*-(E)))- Roseoside aglycon Vomifoliol Using HRMS and NMR". Sci. Total Environ., 2017, 441, 4065-4088.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...